Modeling outcomes in patients with acquired brain injuries
Modeling Trajectories of Functional Outcome in Patients With Severe Acquired Brain Injuries Using a Non-Linear Dynamic Evolution Approach.
This study is testing how artificial intelligence can help predict recovery for people with acquired brain injuries to improve their rehabilitation.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 190 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Istituto per la Ricerca e l'Innovazione Biomedica Academic / other |
| Locations | 1 site (Messina) |
| Trial ID | NCT06162091 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on patients with acquired brain injuries (ABI) to predict recovery trajectories using artificial intelligence algorithms. By analyzing various demographic, clinical, and psychosocial factors, the study aims to improve the understanding of recovery patterns and enhance rehabilitation strategies. Data will be collected from patients diagnosed with severe ABI within three months of the injury, allowing for a comprehensive assessment of recovery potential. The goal is to provide clinicians with better predictive tools for patient outcomes.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 and older who have been diagnosed with severe acquired brain injuries within three months of the event.
Not a fit: Patients with pre-existing disabling neurological or orthopedic conditions and psychiatric disorders may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to more personalized and effective rehabilitation strategies for patients with acquired brain injuries.
How similar studies have performed: Other studies utilizing artificial intelligence for predicting outcomes in brain injuries have shown promise, indicating that this approach may yield valuable insights.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * patients with clinical diagnosis of severe acquired brain injury of different etiology (traumatic, hemorrhagic vascular,ischemic vascular, anoxic, infectious, other etiology * interval since the acute occurrence that led to the clinical condition of ≤3 months duration * age of 18 years or older * informed consent signed by family member/caregiver/supporting caregiver Exclusion Criteria: * Positive remote medical history of pre-existing disabling neurological or orthopedic conditions and psychiatric disorders
Where this trial is running
Messina
- Institute for Biomedical Research and Innovation (IRIB) - National Research Council (CNR) — Messina, Italy (Recruiting)
Study contacts
- Principal investigator: Antonio Cerasa — Institute for Biomedical Research and Innovation (IRIB) - National Research Council (CNR)
- Study coordinator: Antonio Cerasa
- Email: antonio.cerasa@irib.cnr.it
- Phone: +393339633511
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.